Injection site rotation, lipohypertrophy, and the skin you cannot see

What lipohypertrophy actually is

Lipohypertrophy is a localized soft-tissue change that accumulates with repeated injections into the same subcutaneous site. The tissue feels firmer or more elastic on palpation, and it often looks subtly raised. The diabetes injection literature has studied this for decades because it is common and because it matters for dose absorption, not just for cosmetics .

Insulin absorbed from a hypertrophic site is delayed and more variable than insulin absorbed from healthy tissue. The same physical principle applies to subcutaneous peptide therapies: the remodeled tissue is a different pharmacokinetic compartment than the surrounding subcutaneous fat. The clinical literature has documented increased glycemic variability in patients injecting into hypertrophic sites and improved control after rotation .

Why rotation actually helps

• Each injection site experiences a brief inflammatory response. Repeated stimulation of the same micro-region drives chronic low-grade remodeling.
• Rotating across regions (abdomen left and right, thigh left and right, back of upper arm) gives any one micro-region weeks to recover.
• Within a region, rotating by at least one finger-width across consecutive injections substantially reduces hypertrophy incidence in observational data.
• Needle length and gauge influence the depth of insult. Shorter needles reduce the chance of intramuscular delivery, which has different absorption behavior than subcutaneous delivery.

Infection and basic skin care

Injection-site infection is uncommon when basic aseptic technique is followed: clean hands, alcohol swab to a dry skin site, fresh sterile needle, and no shared vials. The CDC and FDA have published consumer-facing safe injection guidance that translates directly across medical and self-administration contexts .

• Stop and seek evaluation if a site develops spreading redness, warmth, fever, or fluctuance.
• Bruising that resolves over a week is generally benign; persistent or expanding bruising is not.
• Avoid injecting through visibly inflamed, broken, or infected skin.